Ƙarƙashin Ƙarƙashin Ƙasa Duk da haka Ana amfani dashi a Melanoma Staging, Clark Level Used Limited
Dikitanku ya ce yourlan melanoma shine mataki IIA (T2bN0M0) da zurfin Breslow na 2 mm.
Ka yi mamakin abin da harshen waje yake magana - hakika, jaririn melanoma yana iya rikicewa da damuwa. Don taimaka maka ka fahimci dalilin da yasa za a zabi wani magani a gare ka, a nan bayanin taƙaitacciyar ma'anar waɗannan kalmomin.
A Melanoma ganewar asali
Idan likitanku ya ga kwayoyin m a yayin jarrabawar fata , mataki na gaba shi ne biopsy fata .
Idan biopsy ya bayyana melanoma, likitan ilimin likita zai bincika biopsy don sanin matakin (cutar) don ya tsara shirin ku.
Bayan lambar TNM , zaka iya ji likita yana amfani da lambar Breslow ko lambar Clark don bayyana bayaninka (hangen zaman gaba). Wadannan hanyoyi guda biyu na gyaran melanoma ne kawai ana amfani da su idan an tsare malanoma, ma'ana ba ya yada zuwa ga wani ƙwayar lymph ko wani kwaya a jiki. Lambar Clark don bayyana bayaninka (hangen zaman gaba). Wadannan hanyoyi guda biyu na gyaran melanoma ne kawai ana amfani da su idan an tsare malanoma, ma'ana ba ya yada zuwa ga wani ƙwayar lymph ko wani kwaya a jiki.
Ga yadda za a fassara su:
Rawanin Ƙasa
Na farko ya ruwaito ta hanyar Alexander Breslow, MD, a shekarar 1970, Girman Breslow yana bayyana matsayin tsayin gine-gine na melanoma, daga saman (wanda ake kira "granular Layer") zuwa yanki mafi zurfi cikin farji.
Ana amfani da kayan aiki da ake kira "micrometer mai kwakwalwa" don auna ma'auni na ciwon da aka cire (cire).
Bugu da ƙari, mafi girma da ƙananan Breslow, mafi muni da ƙaddamarwa-a wasu kalmomi, ƙananan melanoma, mafi girma damar da ya yada. A nan ne farashin rayuwa na tsawon shekaru 5 bisa wani breslow kauri.
Ka tuna cewa waɗannan nauyin rayuwa suna matsakaici kuma bazaiyi la'akari da yanayinka ba:
- kasa da 1 mm: tsawon shekaru 5 yana da kashi 92 zuwa kashi 97 cikin 100-ma'anar 92 zuwa 97 mutane daga cikin 100 mutane zasu kasance da rai shekaru 5 bayan an gano su tare da melanoma wanda bai kai 1mm ba.
- 1.01 zuwa 2 mm: tsawon shekaru 5 yana kusa da kashi 81 zuwa 92 bisa dari
- 2.01 zuwa 4 mm: tsawon shekara 5 yana kusa da kashi 70 zuwa kashi 81
- fiye da 4 mm: tsawon shekaru 5 shine kashi 53 zuwa 70 bisa dari
Saboda daidaituwa a cikin tsinkaya sakamakon, an ƙaddamar da ɗaukar Breslow a tsarin tsarin tsarin TNM na misali don melanoma. A gaskiya ma, Breslow kauri yana da muhimmiyar mahimmanci a cikin melanoma, tare da ciwon sukari (T), da kuma wanzuwar cutar fata (fatar jiki, zub da jini, kumburi).
Clark Level
Tsarin Clark ya nuna yadda zurfin ciwon sukari ya shiga cikin sassan fata . Wannan tsarin shine WH Clark, MD, ya samo asali daga baya, a 1966. An tsara matsayin matakan Clark kamar haka:
- Matsayi na I: An tsara shi zuwa epidermis (filayen fatar fata) wanda ake kira "in situ" melanoma
- Mataki na II: Gwagwarmayar jarrabawa (babba)
- Mataki na III: Cika ɗakun ganyayyaki, amma babu wani tsawo a cikin ƙananan ruɓaɓɓe (ƙananan)
- Matsayi na IV: Gwagwarmayar ƙaddarar reticular
- Mataki na Level: Gwagwarmayar zurfi mai zurfi, nama mai laushi
Duk wannan an ce, ana yin amfani da matakan Clark don yin lissafi a yanzu. Wannan kuwa shi ne saboda bincike ya nuna musu cewa basu da tsinkaye akan sakamakon, ba tare da gurbi ba, kuma mafi mahimmanci fiye da zurfin Breslow. Sauran maras amfani da wannan tsarin ƙirar cewa yana da wuya a bambanta tsakanin Clark Level II da Level III , kuma ba za'a iya amfani dashi ba a kan melanomas na dabino da kuma ɗakuna.
Akwai wani misali wanda zai iya amfani da matakan Clark don hango hangen nesa-a marasa lafiya da marasa lafiya (ƙasa da 1.0 mm) melanoma.
Har ma a lokacin, ana amfani da ita azaman tsoho ne idan ba za'a iya ƙaddamar da nauyin mota na ƙananan melanoma ba. Yanayin mota yana nufin yawan ciwon daji da suke rarraba. Wani haɗari na mota yana nuna cewa ciwon daji zai iya yadawa.
Kalma Daga
Yi ƙoƙari kada ka yi rikici a cikin cikakkun bayanai game da aiwatar da tsarin gyaran malanoma. Maimakon haka, mayar da hankali ga abin da mataki na ciwon daji ke nufi don maganinka da kuma hangen zaman gaba.
> Sources:
> Cibiyar Ciwon Ƙwayar Yammacin Amirka. (Mayu 2016). Melanoma fata ciwon daji matakai.
> Cibiyar Ciwon Ƙwayar Yammacin Amirka. (Mayu 2016). Yaduwar rayuwa don ciwon daji na fata, ta hanyar mataki.
> Balch CM et al. Karshe na 2009 AJCC Melanoma Tsarin da Tsarin. J Jara Incol . 2009 Dec 20; 27 (36): 6199-6206.
> Balch CM, et al. Sakamakon binciken da aka gano na kimanin mutane 17,600 marasa lafiya: Amincewa da kwamitin hadin gwiwar Amurka game da tsarin maganin cutar kanjamau. J Jara Incol . 2001 Aug 15; 19 (16): 3622-34.